EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Targeted exome sequencing strategy ( NeoEXOME ) for Chinese newborns using a pilot study with 3423 neonates

Ziyang Cao, Xiaoyan He, Dongjuan Wang, Maosheng Gu, Feng Suo, Rong Qiang, Ruixue Zhang, Chengrong Song, Xiaohua Wang, Bo Zhu, Donghua Cao, Haihua Yu und 9 weitere

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.2357 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Ziyang Cao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Shanghai Children's Hospital, Shanghai Jiao Tong University Medical School, Shanghai, China. Hauptthemen laut MEDLINE: Neonatal Screening, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chongqing Science and Technology Bureau, Shanghai Hospital Development Center, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Newborn screening (NBS) aims to detect congenital anomalies, and next‐generation sequencing (NGS) has shown promise in this aspect. However, the NBS strategy for monogenic inherited diseases in China remains insufficient.

Methods

We developed a NeoEXOME panel comprising 601 genes that are relevant to the Chinese population found through extensive research on available databases. An interpretation system to grade the results into positive (high‐risk, moderate‐risk, and low‐risk genotypes), negative, and carrier according to the American College of Medical Genetics (ACMG) guidelines was also developed. We validated the panel to evaluate its efficacy by using data from the “1000 Genomes Project” and conducted a pilot multicenter study involving 3423 neonates.

Results

The NGS positive rate in the 1000 Genomes Project was 7.6% (23/301), whereas the rate was 12.0% in the multicenter study, including 3249 recruited neonates. Notably, in 200 neonates, positive per conventional NBS, 58.5% (69/118) showed results consistent with NGS. In the remaining 3049 neonates showing negative results in conventional NBS, 271 (8.9%) were positive per NGS, and nine of them were clinically diagnosed with diseases in the follow‐up.

Conclusion

We successfully designed a NeoEXOME panel for targeted sequencing of monogenic inherited diseases in NBS. The panel demonstrated high performance in the Chinese population, particularly for the early detection of diseases with no biochemical markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningHigh-Throughput Nucleotide SequencingHumansInfant, NewbornPilot ProjectsExome SequencingGenotype

Stichwörter der Autor:innen

NeoEXOME panel performancemonogenic inherited diseasesnewborn screeningpilot studytargeted sequencing

Autor:innen und Institutionen

  • Clinical Research Unit, Shanghai Children's Hospital, Shanghai Jiao Tong University Medical School, Shanghai, China.
  • Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Center for Clinical Molecular Laboratory Medicine of Children's Hospital of Chongqing Medical University, Chongqing, China.
  • Center of Medical Genetics, Xuzhou Maternal and Child Health Care Hospital, Xuzhou, China.
  • Center of Medical Genetics, Northwest Women and Children's Hospital, Xi'an, China.
  • Center of Medical Genetics, Inner Mongolia Maternal and Child Health Care Hospital, Hohhot, China.

ORCID-Profile: Lin Zou

Förderung

  • Chongqing Science and Technology Bureau
  • Shanghai Hospital Development Center
  • Natural Science Foundation of China
  • Chongqing Municipal Science and Technology Bureau
  • National Natural Science Foundation of China

Zitieren

APA

Cao, Z., He, X., Wang, D., Gu, M., Suo, F., Qiang, R., Zhang, R., Song, C., Wang, X., Zhu, B., Cao, D., Yu, H., Qu, Y., Shen, G., Wu, J., Wang, P., Wang, J., Zhang, H., Yan, Z., …, & Zou, L. (2024). Targeted exome sequencing strategy ( NeoEXOME ) for Chinese newborns using a pilot study with 3423 neonates. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2357

Vancouver

Cao Z, He X, Wang D, Gu M, Suo F, Qiang R, et al. Targeted exome sequencing strategy ( NeoEXOME ) for Chinese newborns using a pilot study with 3423 neonates. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2357

BibTeX
@article{Cao2024,
  author = {Cao, Ziyang and He, Xiaoyan and Wang, Dongjuan and Gu, Maosheng and Suo, Feng and Qiang, Rong and Zhang, Ruixue and Song, Chengrong and Wang, Xiaohua and Zhu, Bo and Cao, Donghua and Yu, Haihua and Qu, Yiping and Shen, Guosong and Wu, Jian and Wang, Pengpeng and Wang, Jinxia and Zhang, Hongyang and Yan, Zijun and Yu, Guangjun and Zou, Lin},
  title = {Targeted exome sequencing strategy ( NeoEXOME ) for Chinese newborns using a pilot study with 3423 neonates},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.2357}
}
Kostenlos starten →